Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapsone 5% Gel (SEEGPharm) vs Aczone in Acne Vulgaris
NCT02865005Phase 3Completed
- Sponsor
- SeegPharm
- Start
- Feb 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dapsone in acne vulgaris, sponsored by SeegPharm. Started Feb 2016; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02865005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865005.